The University of Copenhagen is a prestigious public research university in Copenhagen, Denmark. Founded in 1479, the University of Copenhagen is the second-oldest university in Scandinavia after Uppsala University, and ranks as one of the top universities in the Nordic countries, Europe and the world.

During the past decade, Ulrikka Nygaard conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ulrikka Nygaard" #1 collaborator was "Innovation Fund Denmark" with 1 trials as a collaborator and "University of Copenhagen" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ulrikka Nygaard" are "Antibiotic Side Effect" (1 trials), "COVID-19" (1 trials), "Early-Onset Neonatal Sepsis" (1 trials), "Multisystem Inflammatory Syndrome in Children" (1 trials) and "SARS-CoV-2 Infection" (1 trials). Many other conditions were trialed in "Ulrikka Nygaard" in a lesser frequency.

Most popular intervention types in "Ulrikka Nygaard" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Individualized treatment duration strategy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ulrikka Nygaard" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ulrikka Nygaard". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ulrikka Nygaard, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ulrikka Nygaard, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".